SUBSCRIBE
SUBSCRIBE

bioAffinity Technologies, Inc.

IN THE PRESS
Biotech Beach
bioAffinity Technologies Publishes Peer-Reviewed Results of High-Throughput Flow Cytometry Use for Evaluating Lung Health in PLOS ONE
September 14, 2022
 · 
3 min read
Deals
bioAffinity Technologies, Inc. Announces Closing of $7.8 Million Initial Public Offering
September 6, 2022
 · 
5 min read
Deals
bioAffinity Technologies Announces Pricing of IPO
September 1, 2022
 · 
4 min read
Lone Star Bio
bioAffinity Technologies Presents its Cancer Therapeutic Research at Joint ASCB-EMBO Meeting
December 6, 2021
 · 
2 min read
Business
bioAffinity Technologies Announces Xavier T. Reveles Promoted to Vice President of Operations
October 14, 2021
 · 
4 min read
Lone Star Bio
bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer
September 23, 2021
 · 
2 min read
Biotech Beach
bioAffinity Technologies Announces Precision Pathology Services’ Validation of Novel Non-Invasive Early Lung Cancer Test
September 14, 2021
 · 
5 min read
Lone Star Bio
bioAffinity Technologies Publishes Sputum Processing and Innovative High-Throughput Analysis Methods
August 12, 2021
 · 
2 min read
Lone Star Bio
bioAffinity Technologies Presents Scientific Discoveries Advancing Cancer Therapeutics and Diagnostics at Two Global Conferences
June 23, 2021
 · 
3 min read
Business
bioAffinity Technologies Executes Agreement with Fosun Long March to Evaluate CyPath® Lung for Commercialization in China
February 4, 2021
 · 
3 min read
Load More
JOBS